Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
J Hosp Infect ; 43(3): 231-8, 1999 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-10582190

RESUMO

The prevalence of rectal carriage of vancomycin-resistant enterococci (VRE) in two high-risk populations--61 patients admitted to ICU and 92 patients on renal dialysis--was studied longitudinally over a period of six months in a 650-bed general hospital. ICU patients were swabbed weekly and dialysis patients monthly. Enterococcal isolates were fully identified using the ATB identification system, and MICs were determined according to the NCCLS recommendations. Enterococci were isolated in 52 (83.6%) ICU patients and 86 (93.4%) dialysis patients. VRE were recovered at least once in 14 (27%) ICU patients and four (4.8%) dialysis patients. All VRE isolates (MIC of vancomycin > or = 256 micrograms/mL) were resistant to teicoplanin (MIC > or = 32 micrograms/mL; vanA phenotype), 87.5% were ampicillin-resistant, and 92% showed high-level resistance to gentamicin; 88% were E. faecium. The main risk factors for acquisition of VRE included duration of hospitalization in the six months preceding entry into the study and during the survey (P = 0.009 and 0.007 respectively, for ICU patients), and duration of antibiotic administration (P = 0.005, for ICU patients). The impact of vancomycin was most prominent (P = 0.005 for receipt and 0.06 for duration of administration, in ICU patients). Six of the 18 VRE carriers developed bacteraemia, six isolates being vancomycin-susceptible and one vancomycin-resistant (one patient had both). In this study, the first in Israel, a low rectal carriage rate occurred in renal dialysis patients and antibiotic use was the most important risk factor for VRE colonization.


Assuntos
Portador Sadio/microbiologia , Enterococcus faecalis/efeitos dos fármacos , Infecções por Bactérias Gram-Positivas/microbiologia , Reto/microbiologia , Resistência a Vancomicina , Idoso , Idoso de 80 Anos ou mais , Portador Sadio/epidemiologia , Enterococcus faecalis/isolamento & purificação , Feminino , Infecções por Bactérias Gram-Positivas/epidemiologia , Unidades Hospitalares de Hemodiálise/estatística & dados numéricos , Hospitais Gerais/estatística & dados numéricos , Humanos , Unidades de Terapia Intensiva/estatística & dados numéricos , Israel/epidemiologia , Masculino , Pessoa de Meia-Idade , Prevalência , Fatores de Risco
2.
Buenos Aires; Grupo Editor Latinoamericano; 1997. 185 p. (112463).
Monografia | BINACIS | ID: bin-112463
6.
Zh Evol Biokhim Fiziol ; 15(3): 288-94, 1979.
Artigo em Russo | MEDLINE | ID: mdl-473986

RESUMO

Marine bivalve molluscs, the mussel Mytilus galloprovincialis aud the scallop Chlamys (Flexopecten) glaber ponticus, have been injected (intramuscularly or in the haemolymph) with glucose, mammalian insulin, insulin (or insulin-like substance) from molluscs, and anti-insulin serum, checking changes in glucose and fatty acid content of the haemolymph as well as in the content of glycogen and the activity of glycogen synthetase in muscles. After glucose injections, studies were also made on the level of IRI in the haemolymph. Comparison of the data obtained in the present work with those reported earlier for freshwater bivalve molluscs suggests that: 1) metabolic shifts induced by anti-insulin serum are more rapid in vigorous scallops than in sedentary mussels; 2) molluscan insulin (or insulin-like substance) exerts the same effect on metabolic parameters of the molluscs, as mammalian insulin exerts in vertebrates.


Assuntos
Insulina/fisiologia , Moluscos/fisiologia , Animais , Bivalves/metabolismo , Bivalves/fisiologia , Glicemia/metabolismo , Glucose/farmacologia , Hemolinfa/análise , Insulina/sangue , Insulina/farmacologia , Metabolismo dos Lipídeos , Moluscos/metabolismo , Especificidade da Espécie
8.
Zh Evol Biokhim Fiziol ; 14(5): 436-40, 1978.
Artigo em Russo | MEDLINE | ID: mdl-716706

RESUMO

Studies have been made on the content of immunoreactive insulin (IRI) in the blood serum of 10--16-day chick embryos. A totally homologous radioimmune assay system consisting of a standard and labelled chick insulin together with antiinsulin guinea pig serum to chick insulin, was used. The results obtained show that IRI content increases with the age of embryos. Intravascular injection of glucose increases IRI content in embryos of all the ages investigated.


Assuntos
Glucose/farmacologia , Insulina/sangue , Animais , Embrião de Galinha
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA